Point72 Hong Kong LTD Y M Abs Therapeutics, Inc. Call Options Transaction History
Point72 Hong Kong LTD
- $1.5 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding YMAB
# of Institutions
105Shares Held
27.1MCall Options Held
38.4KPut Options Held
2.1K-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$19.6 Million0.96% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.24MShares$15 Million9.97% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$13.6 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$10.2 Million0.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$9.01 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $202M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...